@article{23e8e7ef541c4b8b8a0d1359663510a2,
title = "Reply: Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in the management of major bleeding: Methodological issues",
author = "Abdoellakhan, {Rahat A.} and Jan Beyer-Westendorf and Sam Schulman and Ravi Sarode and Karina Meijer and Nakisa Khorsand",
note = "Funding Information: K. Meijer reports receiving travel support, speaker fees or consulting fees from Baxter, Bayer, Sanquin, Pfizer, Boehringer Ingelheim, BMS, Aspen and Uniqure outside the submitted work. R. Sarode reports receiving personal fees from CSL Behring, Octapharma and Portola outside the submitted work. J. Beyer‐Westendorf reports receiving personal fees from Portola during the conduct of the study, grants and personal fees from Bayer and Daiichi Sankyo, grants from Boehringer Ingelheim and Pfizer, and personal fees from Janssen, outside the submitted work. R. A. Abdoellakhan, S. Schulman and N. Khorsand report no conflicts of interest. ",
year = "2019",
doi = "10.1111/jth.14540",
language = "English (US)",
volume = "17",
pages = "1398--1399",
journal = "Journal of Thrombosis and Haemostasis",
issn = "1538-7933",
publisher = "Wiley-Blackwell",
number = "8",
}